Receptors are proteins that receive and transmit signals from ligands. In cancer, receptors like the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) are often overexpressed, leading to enhanced cell proliferation. Targeting these receptors with specific ligands can help in blocking these signaling pathways, thereby controlling cancer growth.
